40 commercial payer policies list J1602. See each policy's status for the code and its official source. Listing a code is not a coverage decision: read each policy’s source for the requirements that apply.
Free account. Policy pages stay open to everyone.
40 policies from 19 payers
Summary of the payer’s published policy. Not a coverage determination — confirm with the payer before submitting.
Codes labeled “Inferred from policy title” are not listed in the policy document; Backwork attached them because the policy title names the drug.
| Policy | Effective | Status of J1602 |
|---|---|---|
| Golimumab (Simponi Aria)Effective 02/01/2020 - 10/31/2020 | Feb 1, 2020 | Prior auth requiredInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
| Golimumab (Simponi Aria)Effective 02/01/2021 - 10/01/2021 | Feb 1, 2021 | Prior auth requiredInferred from policy title |
| Golimumab (Simponi Aria)Effective 09/01/2022 - 07/31/2023 | Sep 1, 2022 | Prior auth requiredInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
|---|
| Golimumab (Simponi Aria)Effective 10/01/2021 - 08/31/2022 | Oct 1, 2021 | Prior auth requiredInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
|---|
| Golimumab (Simponi Aria)Effective 11/01/2020 - 01/31/2021 | Nov 1, 2020 | Prior auth requiredInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
|---|
| Golimumab (Simponi Aria)Effective 11/02/2018 - 01/31/2020 | Nov 2, 2018 | Prior auth requiredInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
|---|
| Simponi Aria (golimumab) | Jan 1, 2026 | Prior auth requiredInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
|---|
| Simponi Aria (golimumab)Effective 01/01/2024 - 11/30/2024 | Jan 1, 2024 | Prior auth requiredInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
|---|
| Simponi Aria (golimumab)Effective 08/01/2023 - 12/31/2023 | Aug 1, 2023 | Prior auth requiredInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
|---|
| Simponi Aria (golimumab)Effective 12/01/2024 - 12/31/2025 | Dec 1, 2024 | Prior auth requiredInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
|---|
| Policy | Effective | Status of J1602 |
|---|---|---|
| Provider Administered Drugs – Site of Care | Oct 1, 2026 | Covered |
| Simponi Aria (Golimumab) Injection for Intravenous Infusion | Mar 1, 2026 | Covered |
| Simponi Aria (Golimumab) Injection for Intravenous Infusion – Community Plan Medical Benefit Drug Policy | Not recorded | Covered with conditionsInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
| Simponi Aria (Golimumab) Injection for Intravenous Infusion – Individual Exchange Medical Benefit Drug Policy | Not recorded | Covered with conditionsInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
| Policy | Effective | Status of J1602 |
|---|---|---|
| Alzheimer's Disease: Experimental, Investigational, or Unproven Treatments | Feb 20, 2024 | Covered |
| Intradiscal Procedures | Aug 30, 2023 | Covered |
| Golimumab (Simponi and Simponi Aria) | Feb 20, 2024 | Covered with conditionsInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
| Policy | Effective | Status of J1602 |
|---|---|---|
| Golimumab (Simponi Aria) Intravenous (IV) Injection | Not recorded | Covered with conditionsInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
| Golimumab (Simponi Aria) Intravenous (IV) Injection | Not recorded | Covered with conditionsInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
| Policy | Effective | Status of J1602 |
|---|---|---|
| Golimumab | May 15, 2026 | Covered |
| Specialty Medication Administration Site of Care | Jan 1, 2026 | Covered |
| Policy | Effective | Status of J1602 |
|---|---|---|
| Golimumab | May 15, 2026 | Covered |
| Specialty Medication Administration Site of Care | Jan 1, 2026 | Covered |
| Policy | Effective | Status of J1602 |
|---|---|---|
| Golimumab | May 15, 2026 | Covered |
| Specialty Medication Administration Site of Care | Jan 1, 2026 | Covered |
| Policy | Effective | Status of J1602 |
|---|---|---|
| Golimumab | May 15, 2026 | Covered |
| Specialty Medication Administration Site of Care | Jan 1, 2026 | Covered |
| Policy | Effective | Status of J1602 |
|---|---|---|
| Golimumab (Simponi Aria) Intravenous (IV) Injection | Not recorded | Covered with conditionsInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
| Golimumab (Simponi Aria) Intravenous (IV) Injection | Not recorded | Covered with conditionsInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
| Policy | Effective | Status of J1602 |
|---|---|---|
| Provider Administered Drugs – Site of Care | Oct 1, 2026 | Covered |
| Simponi Aria (Golimumab) Injection for Intravenous Infusion | Mar 1, 2026 | Covered |
| Policy | Effective | Status of J1602 |
|---|---|---|
| Golimumab (e.g., Simponi Aria) | Not recorded | Covered with conditionsInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
| Policy | Effective | Status of J1602 |
|---|---|---|
| Golimumab Simponi Aria | Not recorded | Covered with conditionsInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
| Policy | Effective | Status of J1602 |
|---|---|---|
| Simponi Aria (Golimumab) for Intravenous Use | Not recorded | Covered with conditionsInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
| Policy | Effective | Status of J1602 |
|---|---|---|
| Golimumab (Simponi ARIA) | Sep 4, 2013 | Covered with conditionsInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
| Policy | Effective | Status of J1602 |
|---|---|---|
| Simponi Aria (Golimumab Injection for Intravenous Use) | Not recorded | Covered with conditionsInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
| Policy | Effective | Status of J1602 |
|---|---|---|
| Golimumab (Simponi Aria) | Not recorded | Covered with conditionsInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
| Policy | Effective | Status of J1602 |
|---|---|---|
| 00223 golimumab (Simponi Aria, Simponi) | Not recorded | Covered with conditionsInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
| Policy | Effective | Status of J1602 |
|---|---|---|
| Simponi ARIA (golimumab) | Not recorded | Covered with conditionsInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
| Policy | Effective | Status of J1602 |
|---|---|---|
| Simponi Aria (Golimumab) Injection for Intravenous Infusion | Mar 1, 2026 | Covered |